Objectives

1. Identify outcomes of use of apixaban and potential reduction to risk of bleeding compared with warfarin in ESRD patients.

Session date: 
Thursday, September 20, 2018 - 1:00pm to 2:00pm
Speaker Name: 
Dr. Saurabh Chawla
Location: 
UCMC AMB W-507
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.